Brief: Lucira Health's Covid-19 & Flu At-Home Molecular Test Shows Positive Clinical Study Results
29/03/2022 12:19
March 29 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA HEALTH'S COVID-19 & FLU AT-HOME MOLECULAR TEST
SHOWS
POSITIVE CLINICAL STUDY RESULTS
* LUCIRA HEALTH INC- REGULATORY SUBMISSIONS ARE PLANNED FOR
Q2
2022 WITH DECISIONS EXPECTED BEFORE UPCOMING NORTHERN HEMISPHERE
FLU SEASON
Source text for Eikon: ID:nPnbjzm3ma
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process